Sialylated fetuin-A as a marker of immunotherapy efficacy

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10884002
APP PUB NO 20170370946A1
SERIAL NO

15528250

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention concerns the identification of specific polypeptides, fragments variants thereof which can be used as markers for the efficacy of immunotherapy, particular for predicting responsiveness of a patient to immunotherapy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
STALLERGENES92160 ANTONY

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bodo, Véronique Palaiseau, FR 4 4
Bouley, Julien Le Grand Lemps, FR 5 6
Caillot, Noémie Paris, FR 3 0
Lombardi, Vincent Antony, FR 5 8
Moingeon, Philippe Verrieres le Buisson, FR 24 73
Nony, Emmanuel Antony, FR 36 246

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Jul 5, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 5, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00